Does continuous positive airway pressure therapy improve non-alcoholic fatty liver disease?

Respirology

Volumn 21, Issue 2, 2016, Pages 209-210

  Kohler, Malcolm ^a,b   Stradling, John R ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

continuous positive airway pressure; liver injury; non alcoholic fatty liver disease; non alcoholic steatohepatitis; obstructive sleep apnoea

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; TRIACYLGLYCEROL;

COMPUTER ASSISTED TOMOGRAPHY; DISABILITY SEVERITY; DISEASE COURSE; EDITORIAL; FATTY LIVER; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMITTENT HYPOXIA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; OBSERVATIONAL STUDY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; SLEEP APNEA, OBSTRUCTIVE;

CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; SLEEP APNEA, OBSTRUCTIVE;

EID: 84955252017     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12720     Document Type: Editorial

References (12)

1. Mirrakhimov AE, Polotsky VY,. Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? Front. Neurol. 2012; 3: 149.
2. Chou TC, Liang WM, Wang CB, Wu TN, Hang LW,. Obstructive sleep apnea is associated with liver disease: a population-based cohort study. Sleep Med. 2015; 16: 955-960.
3. Aron-Wisnewsky J, Minville C, Tordjman J, Levy P, Bouillot JL, Basdevant A, Bedossa P, Clement K, Pepin JL,. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J. Hepatol. 2012; 56: 225-233.
4. Qi JC, Huang JC, Lin QC, Zhao JM, Lin X, Chen LD, Huang JF, Chen X,. Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults. Sleep Breath. 2015.
5. Chin K, Nakamura T, Takahashi K, Sumi K, Ogawa Y, Masuzaki H, Muro S, Hattori N, Matsumoto H, Niimi A, et al. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am. J. Med. 2003; 114: 370-376.
6. Shpirer I, Copel L, Broide E, Elizur A,. Continuous positive airway pressure improves sleep apnea associated fatty liver. Lung 2010; 188: 301-307.
7. Kohler M, Pepperell JC, Davies RJ, Stradling JR,. Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial. Respiration 2009; 78: 141-146.
8. Sivam S, Phillips CL, Trenell MI, Yee BJ, Liu PY, Wong KK, Grunstein RR,. Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur. Respir. J. 2012; 40: 913-918.
9. Kohler M, Pepperell JC, Casadei B, Craig S, Crosthwaite N, Stradling JR, Davies RJ,. CPAP and measures of cardiovascular risk in males with OSAS. Eur. Respir. J. 2008; 32: 1488-1496.
10. Lam JC, Lam B, Yao TJ, Lai AY, Ooi CG, Tam S, Lam KS, Ip MS,. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur. Respir. J. 2010; 35: 138-145.
11. Hoyos CM, Killick R, Yee BJ, Phillips CL, Grunstein RR, Liu PY,. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax 2012; 67: 1081-1089.
12. Jullian-Desayes ITR, Zarski JP, Aron-Wisnewsky J, Launois-Rollinat SH, Trocme C, Levy P, Joyeux-Faure M, Pepin JL,. Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: data from randomized trials. Respirology 2016; 21: 378-385.